Clinical Trial

Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

Name: Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine — clinical trial record (NCT07379151)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PERS-ACYWX-03

Recruiting

View on ClinicalTrials.gov →

Summary

This study will measure immune persistence of the NmCV-5 more than 5 years after a single dose vaccination in participants 2-29 years of age in Mali and The Gambia.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-04

Trial Details

NCT Number	NCT07379151
Lead Sponsor	Serum Institute of India Pvt. Ltd.
Conditions	Meningoccocal Disease
Enrollment	450 participants
Start Date	2026-05-05
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-03